心泰医疗2024中期报告

Stock Code 股份代號 : 2291 Contents 26911384546505355 Definitions In this report, the following expressions have the meanings setout below unless the context requires otherwise: Definitions Beijing Target Medical Technologies Co., Ltd.# (), a limited liability company established in the PRCon November 18, 1999 and a wholly-owned subsidiary of LepuMedical, one of the controlling shareholders of the Company19991118 Corporate Information BOARD OF DIRECTORS Executive DirectorMs. Chen Juan(Chairman) Non-Executive Directors Ms. Zhang YuxinMr. Fu ShanMr. Zheng Guorui Independent Non-Executive Directors 20247 2620247 26 Ms. Chan Ka Lai VanessaMr. Zheng YufengMr. Liu Daozhi(resigned on July 26, 2024)Mr. Zheng Junwei(appointed on July 26, 2024) SUPERVISORS Mr. Wang XinglinMs. Wang XiaoyongMr. Qian Weidong AUDIT COMMITTEE Ms. Chan Ka Lai Vanessa(Chairperson)Mr. Zheng GuoruiMr. Zheng Yufeng REMUNERATION COMMITTEE 20247 2620247 26 Mr. Zheng Yufeng(Chairperson)Ms. Chen JuanMr. Fu ShanMs. Chan Ka Lai VanessaMr. Liu Daozhi(resigned on July 26, 2024)Mr. Zheng Junwei(appointed on July 26, 2024) NOMINATION COMMITTEE 20247 2620247 26 Ms. Chen Juan(Chairperson)Mr. Zheng GuoruiMs. Chan Ka Lai VanessaMr. Zheng YufengMr. Liu Daozhi(resigned on July 26, 2024)Mr. Zheng Junwei(appointed on July 26, 2024) Corporate Information JOINT COMPANY SECRETARIES 20248 2220248 22 Mr. Qin XueMr. Li Kin Wai(appointed on August 22, 2024)Ms. Ko Mei Ying(resigned on August 22, 2024) AUTHORIZED REPRESENTATIVES 20248 2220243 120248 2220243 1 Ms. Chen JuanMr. Li Kin Wai(appointed on August 22, 2024)Ms. Ko Mei Ying(appointed on March 1, 2024and resigned on August 22, 2024)Ms. Zhang Yuxin(resigned on March 1, 2024) LEGAL ADDRESS IN THE PRC 25841201 Room 201Building 41No. 258, Xinzhuan RoadSongjiang DistrictShanghaiPRC ADDRESS OF HEAD OFFICE IN THE PRC 2584115 1/F, 5/FBuilding 41No. 258, Xinzhuan RoadSongjiang DistrictShanghaiPRC PRINCIPAL PLACE OF BUSINESS IN HONGKONG 5/F, Manulife Place348 Kwun Tong RoadKowloonHong Kong 3485 AUDITORS BDO China Shu Lun Pan Certified Public Accountants LLP Corporate Information LEGAL ADVISORS As to Hong Kong lawWilson Sonsini Goodrich & Rosati ••• As to PRC lawHaiwen & Partners HONG KONG SHARE REGISTRAR Tricor Investor Services Limited17/F, Far East Finance Centre16 Harcourt RoadHong Kong 1617 PRINCIPAL BANKS Bank of ShanghaiChina Merchants BankIndustrial and Commercial Bank of ChinaBank of Ningbo COMPANY WEBSITE http://www.scientechmed.com/ http://www.scientechmed.com/ LISTING DATE 2022118 November 8, 2022 STOCK CODE 2291 2291 Financial Highlights 2023630166.449.7%2024630249.1 –Revenue increased by 49.7% from RMB166.4 million forthe six months ended June 30, 2023 to RMB249.1 millionfor the six months ended June 30, 2024. 2023630147.753.4%2024630226.7 –Gross profit increased by 53.4% from RMB147.7 millionfor the six months ended June 30, 2023 to RMB226.7million for the six months ended June 30, 2024. –Research and development expenses decreased by 21.3%from RMB27.6 million for the six months ended June 30,2023 to RMB21.7 million for the six months ended June30, 2024. 2 0 2 363 027.621.3%202463021.7 202363075.685.6%2024630140.2 –Netprofit attributable to shareholders of the parentcompany increased by 85.6% from RMB75.6 million forthe six months ended June 30, 2023 to RMB140.2 millionfor the six months ended June 30, 2024. Financial Highlights Notes: (1)2010122024482024523202448202371720244192024202463020232023 (1)Accordingto the“Consultation Conclusions on AcceptanceofMainland Accounting and Auditing Standards and MainlandAudit Firms for Mainland Incorporated Companies Listed in HongKong”()publishedbythe Stock Exchange in December 2010,PRC incorporatedissuers listed in Hong Kong are allowed to prepare their financialstatements in accordance with the China Accounting StandardsforBusiness Enterprises(the“CASBE”)and PRC audit firmsapproved by the Ministry of Finance of the PRC and the ChinaSecurities Regulatory Commission are allowed to adopt the ChinaStandardson Auditing in providing services to such issuers.Inorder to improve working efficiency,lower disclosure costsand audit costs, on April 8, 2024, the Board has approved tochange the overseas financial report disclosure standards of theGroup from the International Financial Reporting Standards to theCASBE. The annual general meeting was held and approved thecorresponding changes to the Articles of Association on May 23,2024. For details, please refer to the Company’s announcementsdated April 8, 2024 and July 17, 2023 and the circular of theCompanydated April 19,2024.The Group will disclose itsfinancial reports according to the CASBE and relevant regulationssince 2024. The Group’s financial statements and interim resultsfor the six months ended June 30, 2024 have been preparedunder the CASBE, and the relevant comparative figures for 2023have been appropriately adjusted pursuant to the CASBE. Figuresfor th